Literature DB >> 6656987

Estimation of levels of IgG to multiple sclerosis specific brain antigens in the cerebrospinal fluid of MS patients.

S C Rastogi, J Clausen, H J Hansen, E Pedersen, W W Tourtellotte.   

Abstract

The binding of partially purified multiple sclerosis (MS) specific brain antigens (MSG2) and of the corresponding antigens of non-MS brains (KG2) to cerebrospinal fluid IgG of patients with MS and other neurological diseases was assayed employing sandwich enzyme linked immunosorbent assay (ELISA). Assay of the antigen-antibody binding revealed that the concentration of MSG2 required for the optimum binding to IgG in the undiluted MS CSFs was lower than that of KG2 in all cases. The index for IgG binding capacity of an antigen (IgBC) was expressed as a ratio of the optical density of the enzymic products in ELISA at the optimal antigen-antibody binding to the lowest concentration of the antigen required for the optimal binding. The IgBC of MSG2 was found to be linearly correlated with the IgG concentration in the CSF of MS patients. These results indicate that IgG with specificity to MSG2 may be present in the CSF of MS patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6656987     DOI: 10.1007/BF00963996

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  14 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Partial purification of MS specific brain antigens.

Authors:  S C Rastogi; J Clausen; H Offner; G Konat; T Fog
Journal:  Acta Neurol Scand       Date:  1979-06       Impact factor: 3.209

3.  Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Chemical and immunological characterisation with special reference to multiple sclerosis.

Authors:  H Link
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

4.  Immunoglobulin synthesis within the central nervous system in disseminated sclerosis.

Authors:  S Cohen; R Bannister
Journal:  Lancet       Date:  1967-02-08       Impact factor: 79.321

5.  The quantitation of pregnancy specific beta 1-glycoprotein by enzyme linked immunoassay.

Authors:  D J MacDonald; A Belfield; C J Steele; D S Mack; M M Shah
Journal:  Clin Chim Acta       Date:  1979-05-16       Impact factor: 3.786

6.  In vitro IgG synthesis by peripheral blood lymphocytes of multiple sclerosis patients and normal individuals. Effect of multiple sclerosis and non-multiple sclerosis brain antigens.

Authors:  S C Rastogi; N H Birkeboek
Journal:  Eur Neurol       Date:  1983       Impact factor: 1.710

7.  Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy.

Authors:  B Ryberg
Journal:  J Neurol Sci       Date:  1978-10       Impact factor: 3.181

8.  Multiple sclerosis: correlation between immunoglobulin-G in cerebrospinal fluid and brain.

Authors:  W W Tourtellotte; J A Parker
Journal:  Science       Date:  1966-11-25       Impact factor: 47.728

9.  Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

Authors:  E Norrby; H Link; J E Olsson; M Panelius; A Salmi; B Vandvik
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

10.  Antibodies against viruses and structural brain components in oligoclonal IgG obtained from multiple sclerosis brain.

Authors:  B Roström
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

View more
  2 in total

1.  Double ligand ELISA technique for the estimation of antibodies to brain tissue antigens in patients with neurological disorders.

Authors:  L Bologa; W Hofstetter; K Schonenberger; C Jacque; N Herschkowitz
Journal:  Neurochem Res       Date:  1985-04       Impact factor: 3.996

2.  HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors.

Authors:  Jeffrey A Rumbaugh; Muznabanu Bachani; Wenxue Li; Tracy R Butler; Katherine J Smith; Mario A Bianchet; Tongguang Wang; Mark A Prendergast; Ned Sacktor; Avindra Nath
Journal:  Neurobiol Dis       Date:  2012-08-25       Impact factor: 5.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.